L. Lagunes, B. Borgatta, M. T. Martín-Gomez, A. Rey-Pérez, M

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Helicobacter pylori resistance to antibiotics in 2014 in France detected by phenotypic and genotypic methods A. Ducournau, L. Bénéjat, E. Sifré, E. Bessède,

L. Boyanova Clinical Microbiology and Infection

Gut bacterial microbiota and obesity

I.J. Schalk Clinical Microbiology and Infection

Approach to diagnosis of infective endocarditis

Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience H. Asgeirsson, A. Thalme, M. Kristjansson,

Anidulafungin for the treatment of invasive candidiasis

Prolonged viral shedding in pandemic influenza A(H1N1): clinical significance and viral load analysis in hospitalized patients M. Giannella, M. Alonso,

Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis T. Steinmetz, N.

Migrant health—a cause for concern?

J. M. Pereira, R. P. Moreno, R. Matos, A. Rhodes, I. Martin-Loeches, M

J. M. Pereira, R. P. Moreno, R. Matos, A. Rhodes, I. Martin-Loeches, M

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Clinical and microbiological outcome in septic patients with extremely low 25- hydroxyvitamin D levels at initiation of critical care G. De Pascale, M.S.

Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients M. Ruhnke, J.A. Paiva, W. Meersseman, J. Pachl,

Easy synergism for colistin-resistant KPC-producing Klebsiella pneumoniae: the E-test with supplemented agar E. Tagliaferri, C. Tascini, A. Leonildi,

Treatment of complicated skin and skin structure infections in areas with low incidence of antibiotic resistance—a retrospective population based study.

M. Giannella, B. Pinilla, J. A. Capdevila, J. Martínez Alarcón, P

R. Cantón Clinical Microbiology and Infection

A. F. Simonetti, C. Garcia-Vidal, D. Viasus, D. García-Somoza, J

Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013 L.E.B. Nabarro, R.A. Lever, M. Armstrong,

Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice? T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt

Potential risk factors for infection with Candida spp

F. Rodríguez-Gómez, O. Cuevas, J. Anguita, P. Muñoz

Assessment of nephrotoxicity in patients receiving amphotericin B lipid complex: a pharmacosurveillance study in Spain J.-M. Aguado, C. Lumbreras, D.

Vector control: a cornerstone in the malaria elimination campaign

J.P. Donnelly, B.E. De Pauw Clinical Microbiology and Infection

C. Garcia-Vidal, I. Sanchez-Rodriguez, A. F. Simonetti, J. Burgos, D

Switch to oral antibiotics in the treatment of infective endocarditis is not associated with increased risk of mortality in non–severely ill patients

Training for the infectious diseases speciality in Norway

F. Grill, P. Muñoz, R. Jofre, E. Bouza

Laboratory diagnosis and biosafety issues of biological warfare agents

C. Fabrizio, A. Procopio Clinical Microbiology and Infection

Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia M. Bassetti, E.M. Trecarichi, A. Mesini,

Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman Clinical.

Early invasive fungal infections and colonization in patients with cirrhosis admitted to the intensive care unit E. Theocharidou, B. Agarwal, G. Jeffrey,

Levofloxacin in the treatment of ventilator-associated pneumonia

R. Bitterman, M. Paul, D. Polak, Y. Geffen

Metagenomics and probiotics

M. Aires-de-Sousa Clinical Microbiology and Infection

Previously unknown species of Aspergillus

Laboratory diagnosis of Clostridium difficile disease

Systematic review of antibiotic consumption in acute care hospitals

M. Bassetti, M.P. Molinari, M. Mussap, C. Viscoli, E. Righi

Effect of metronidazole versus standard care on length of stay of patients admitted with severe infectious mononucleosis: a randomized controlled trial

Characterization of clinical strains of Aspergillus terreus complex: molecular identification and antifungal susceptibility to azoles and amphotericin.

Testing patients with non-specific symptoms for antibodies against Borrelia burgdorferi sensu lato does not provide useful clinical information about.

Tuberculosis transmission patterns among Spanish-born and foreign-born populations in the city of Barcelona S. Borrell, G. Tudó, E. Rey, J. González-Martín

Current experience in treating invasive zygomycosis with posaconazole

Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia M.-S. Hsu,

Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013 U. Fedeli, E. Schievano,

Statin use and clinical outcomes among pneumonia patients

M.T. Pérez-Rodríguez, A. Sousa, P. Martínez-Cueto, A. Ocampo

A. van Samkar, M. C. Brouwer, Y. Pannekoek, A. van der Ende, D

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Abstracts Clinical Microbiology and Infection

Virology: a scientific discipline facing new challenges

Update on invasive aspergillosis: clinical and diagnostic aspects

Initial serum (1,3)-β-d-glucan as a predictor of mortality in proven candidaemia: findings from a retrospective study in two teaching hospitals in Italy.

J.L. Balcázar Clinical Microbiology and Infection

Great oaks from little acorns grow—21 years of CMI

J.A. Pérez-Molina, F. Fernández Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain M. Puig-Asensio,

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection A. Russo, M. Falcone, M. Fantoni, R. Murri,

Presentation transcript:

Predictors of choice of initial antifungal treatment in intraabdominal candidiasis L. Lagunes, B. Borgatta, M.T. Martín-Gomez, A. Rey-Pérez, M. Antonelli, E. Righi, M. Merelli, P. Brugnaro, G. Dimopoulos, J. Garnacho- Montero, A.L. Colombo, R. Luzzati, F. Menichetti, P. Muñoz, M. Nucci, G. Scotton, C. Viscoli, M. Tumbarello, M. Bassetti, J. Rello F. Ansaldi, C. Scarparo, A. Diaz-Martin, I. Palacios-Garcia, C. Rosin, B. Almirante, G. Baldin, A. Vena, E. Bouza, V. de Egea, C. Tascini, F. Menichetti, E. Tagliaferri, M. Sanguinetti, A. Mesini, G. Sganga, M. Busetti, T. Pumarola, M.T. Martin, S.A. Nouér, T. Pelaez, E. Raise, S. Grandesso, V. Del Bono, P. Esteves, C. Trucchi, A. Sartor, G. De Pascale, B. Posteraro, C. Scarparo, P. Esteves L. Lagunes, B. Borgatta, M.T. Martín-Gomez, A. Rey-Pérez, M. Antonelli, E. Righi, M. Merelli, P. Brugnaro, G. Dimopoulos, J. Garnacho-Montero, A.L. Colombo, R. Luzzati, F. Menichetti, P. Muñoz, M. Nucci, G. Scotton, C. Viscoli, M. Tumbarello, M. Bassetti, J. Rello F. Ansaldi, C. Scarparo, A. Diaz-Martin, I. Palacios-Garcia, C. Rosin, B. Almirante, G. Baldin, A. Vena, E. Bouza, V. de Egea, C. Tascini, F. Menichetti, E. Tagliaferri, M. Sanguinetti, A. Mesini, G. Sganga, M. Busetti, T. Pumarola, M.T. Martin, S.A. Nouér, T. Pelaez, E. Raise, S. Grandesso, V. Del Bono, P. Esteves, C. Trucchi, A. Sartor, G. De Pascale, B. Posteraro, C. Scarparo, P. Esteves Clinical Microbiology and Infection Volume 22, Issue 8, Pages 719-724 (August 2016) DOI: 10.1016/j.cmi.2016.06.005 Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 Total population and treatment group, Echinocandin versus azole group; after exclusion of no treated patients and those who received amphotericin. Clinical Microbiology and Infection 2016 22, 719-724DOI: (10.1016/j.cmi.2016.06.005) Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions